Adropin as a potential marker of enzyme-positive acute coronary syndrome

Aydin S., Eren M. N. , Yilmaz M., Kalayci M., Yardim M., Alatas O. D. , ...Daha Fazla

CARDIOVASCULAR JOURNAL OF AFRICA, cilt.28, sa.1, ss.40-47, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Konu: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.5830/cvja-2016-055
  • Sayfa Sayıları: ss.40-47


Aim: Enzyme-positive acute coronary syndrome (EPACS) can cause injury to or death of the heart muscle owing to prolonged ischaemia. Recent research has indicated that in addition to liver and brain cells, cardiomyocytes also produce adropin. We hypothesised that adropin is released into the bloodstream during myocardial injury caused by acute coronary syndrome (ACS), so serum and saliva levels rise as the myocytes die. Therefore, it could be useful to investigate how ACS affects the timing and significance of adropin release in human subjects.